4//SEC Filing
Cox John 4
Accession 0000950170-25-035495
CIK 0001818794other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:07 PM ET
Size
8.6 KB
Accession
0000950170-25-035495
Insider Transaction Report
Form 4
Cox John
DirectorCEO & President
Transactions
- Sale
Common Stock
2025-03-05$11.83/sh−4,061$48,042→ 146,239 total
Holdings
- 8,000(indirect: By Trust)
Common Stock
- 8,000(indirect: By Trust)
Common Stock
- 8,000(indirect: By Trust)
Common Stock
- 8,000(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 4, 2024. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $11.73 to $11.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.
- [F3]Includes 136,219 unvested RSUs.
- [F4]These shares are held in a trust for the benefit of a child of the Reporting Person.
Documents
Issuer
Dyne Therapeutics, Inc.
CIK 0001818794
Entity typeother
Related Parties
1- filerCIK 0001498428
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 4:07 PM ET
- Size
- 8.6 KB